SCHEMBL21573329

SCHEMBL21573329

CCNc1nc(NC(C)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 19/20 0.52
▸ IDH2 P48735 5/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21573480 1.00 IDH1 (0.52) IDH1IDH2
SCHEMBL16370163 0.91 IDH1 (0.57) IDH1IDH2
SCHEMBL17971624 0.88 IDH1 (0.58) IDH1IDH2
SCHEMBL21573412 0.83 IDH1 (0.67) IDH1IDH2
SCHEMBL21573402 0.83 IDH1 (0.51) IDH1IDH2
SCHEMBL16393080 0.80 IDH1 (0.57) IDH1IDH2
SCHEMBL18557120 0.79 IDH1 (0.53) IDH1IDH2
SCHEMBL21573411 0.78 IDH1 (0.50) IDH1IDH2
SCHEMBL16392810 0.76 IDH1 (0.67) IDH1IDH2
SCHEMBL21573226 0.75 IDH1 (0.84) IDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019483-B1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS INC (US) 2019-11-20 — — EP disclosed
Send feedback